Kaylie Buras
Family · Covington, LANPI 1184350852
Payments from drug & device makers
Across 16 payments — averaging $47.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$282
- UCB, Inc.$125
- Acadia Pharmaceuticals Inc$115
- Otsuka Pharmaceutical Development & Commercialization, Inc.$85
- Novo Nordisk$30
- Alpha Cognition USA, Inc.$28
- plus $90 from 5 others
What the payments were for
- Food & beverage$753100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $282 |
| UCB, Inc. | 1 | $125 |
| Acadia Pharmaceuticals Inc | 1 | $115 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $85 |
| Novo Nordisk | 2 | $30 |
| Alpha Cognition USA, Inc. | 1 | $28 |
| Nestle Healthcare Nutrition Inc. | 1 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$753 in reported general payments places this provider in the 55th percentile of 3,610 family providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 56 | $37,859 |
| Metoprolol Succinate | 42 | $1,251 |
| Megestrol Acetate | 16 | $874 |
| Levothyroxine Sodium | 49 | $845 |
| Rosuvastatin Calcium | 26 | $834 |
| Nystatin | 27 | $808 |
| Divalproex Sodium | 27 | $757 |
| Potassium Chloride | 20 | $745 |
| Fluticasone Propionate | 29 | $701 |
| Memantine Hcl | 25 | $690 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $625 |
| Atorvastatin Calcium | 30 | $617 |
| Hydralazine Hcl | 14 | $589 |
| Buspirone Hcl | 21 | $497 |
| Escitalopram Oxalate | 32 | $487 |
Paid to pharmacies, not to this prescriber.
Other family in Covington
- Karolina RuthnerCovington$17K
- Pamela EganCovington$15K
- Jeffrey KitchCovington$13K
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.